Cargando…

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer

BACKGROUND: Previous studies have reported that neoadjuvant chemoradiotherapy can downstage the advanced gastric cancer. However, no studies are available on the application of hypo-radiotherapy to neoadjuvant radiotherapy. This study sought to assess the maximum tolerated dose (MTD) and dose-limite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ning, Wang, Xin, Tang, Yuan, Zhao, Dongbing, Chi, Yihebali, Yang, Lin, Jiang, Liming, Jiang, Jun, Liu, Wenyang, Tang, Yu, Fang, Hui, Liu, Yueping, Song, Yongwen, Wang, Shulian, Jin, Jing, Li, Yexiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083620/ https://www.ncbi.nlm.nih.gov/pubmed/30089457 http://dx.doi.org/10.1186/s12885-018-4707-9

Ejemplares similares

Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
por: Li, Ning, et al.
Publicado: (2022)

Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
por: Li, Ning, et al.
Publicado: (2021)

Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
por: Shi, Jinming, et al.
Publicado: (2022)

Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy
por: Shi, Jinming, et al.
Publicado: (2022)

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
por: Wang, Jianyang, et al.
Publicado: (2016)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy
por: Wang, Weihu, et al.
Publicado: (2010)

Inter‐ and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free‐breathing postoperative radiation analyzed by cone‐beam computed tomography
por: Zhang, Tao, et al.
Publicado: (2014)

Radiomics Analysis of Fat-Saturated T2-Weighted MRI Sequences for the Prediction of Prognosis in Soft Tissue Sarcoma of the Extremities and Trunk Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Comparison of outcome and toxicity of postoperative intensity‐modulated radiation therapy with two‐dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk
por: Wang, Jianyang, et al.
Publicado: (2019)

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
por: Wang, Jianyang, et al.
Publicado: (2015)

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy
por: Zhao, Xuran, et al.
Publicado: (2020)

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
por: Wang, Shulian, et al.
Publicado: (2020)

Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)

Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
por: Yu, Jing, et al.
Publicado: (2016)

Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects
por: Belfatto, Antonella, et al.
Publicado: (2018)

Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)

Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
por: Zach, Leor, et al.
Publicado: (2021)

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy
por: Chen, Xinyuan, et al.
Publicado: (2020)

A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
por: Uttam, Aditya Kumar, et al.
Publicado: (2023)

Predicting pathological complete response of neoadjuvant radiotherapy and targeted therapy for soft tissue sarcoma by whole-tumor texture analysis of multisequence MRI imaging
por: Miao, Lei, et al.
Publicado: (2022)

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
por: Yang, Siran, et al.
Publicado: (2023)

Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy
por: Mushonga, Melinda, et al.
Publicado: (2023)

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy
por: Wang, Jianyang, et al.
Publicado: (2020)

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
por: Paliwal, Rajan, et al.
Publicado: (2012)

Re-irradiation with hypo-fractionated stereotactic robotic radiotherapy for salvage in adult patients with brainstem glioma
por: Susheela, Sridhar P, et al.
Publicado: (2013)

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial
por: Sun, Sun, et al.
Publicado: (2022)

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
por: Meng, FanJun, et al.
Publicado: (2022)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypo-fractionated radiotherapy alone for the treatment of localised prostate cancer
por: Crowther, Karen, et al.
Publicado: (2019)

Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study
por: Wang, Xin, et al.
Publicado: (2022)

Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer
por: Wang, Xin, et al.
Publicado: (2021)

Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
por: Roger, Anissa, et al.
Publicado: (2018)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
por: Martinage, Geoffrey, et al.
Publicado: (2019)

Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
por: Chen, Hongxia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_da2def3ss36ref2ttbsc44f5hc